📅 7:00 PM EST | 🔗 bit.ly/2025BCsky
💬 Expert insights + LIVE Q&A
❓ Submit your questions in advance & engage with the faculty!
📅 7:00 PM EST | 🔗 bit.ly/2025BCsky
💬 Expert insights + LIVE Q&A
❓ Submit your questions in advance & engage with the faculty!
Missed @drsgraff.bsky.social's #Xthread on HR+, HER2- MBC? Now’s your chance to engage! We’re bringing the conversation to LinkedIn—vote in polls, share insights, and discuss real-world cases.
📢 Case #1 is live—join in! 🔗 bit.ly/PollQ-1
Missed @drsgraff.bsky.social's #Xthread on HR+, HER2- MBC? Now’s your chance to engage! We’re bringing the conversation to LinkedIn—vote in polls, share insights, and discuss real-world cases.
📢 Case #1 is live—join in! 🔗 bit.ly/PollQ-1
🔗 Register now: bit.ly/GynOnc25sky foundationforwomenscancer.org
#medsky #oncsky
🔗 Register now: bit.ly/GynOnc25sky foundationforwomenscancer.org
#medsky #oncsky
Join PeerView for an interactive, workshop-style live event at the #SSO2025 Annual Meeting! 🚀
📅 March 27 | 7:30 PM EDT
In-Person and Virtual otions available
🩺 Drs. Jennifer Wargo | Charlotte E. Ariyan | Nikhil I. Khushalani
🔗 bit.ly/MelanomaSky
#Melanoma #Oncology #OncSky #Medsky
💡 Transform your #EoE care with expert guidance in the EoE @projectechohq.bsky.social Program. Explore the latest in targeted therapy for EoE.
Don't miss out—register now! ⬇️
🔗 bit.ly/EoEECHO
💡 Transform your #EoE care with expert guidance in the EoE @projectechohq.bsky.social Program. Explore the latest in targeted therapy for EoE.
Don't miss out—register now! ⬇️
🔗 bit.ly/EoEECHO
Are you ready for the next case segment? Our patient with HR+, HER2- #MBC has developed diarrhea 💩 while receiving 1L Tx with a CDK4/6i 💊. Answer the poll 📊 in the following post, explain why in a comment 💬, and see how your answer compares with those of your peers. @peerview.bsky.social
Are you ready for the next case segment? Our patient with HR+, HER2- #MBC has developed diarrhea 💩 while receiving 1L Tx with a CDK4/6i 💊. Answer the poll 📊 in the following post, explain why in a comment 💬, and see how your answer compares with those of your peers. @peerview.bsky.social
📝 Be ready for Case #2 and Poll #2! 📊 #MBC #CME #PeerView #medsky #oncsky
Are you ready for the next case segment? Our patient with HR+, HER2- #MBC has developed diarrhea 💩 while receiving 1L Tx with a CDK4/6i 💊. Answer the poll 📊 in the following post, explain why in a comment 💬, and see how your answer compares with those of your peers. @peerview.bsky.social
📝 Be ready for Case #2 and Poll #2! 📊 #MBC #CME #PeerView #medsky #oncsky
📅 Feb 13-14 | In-Person & Virtual
🧬 AKT inhibitors, immunotherapy, & team-based strategies
Register now! 🔗 bit.ly/ASCOGU25sky
#oncsky #medsky zerocancer.org | bcan.org
📅 Feb 13-14 | In-Person & Virtual
🧬 AKT inhibitors, immunotherapy, & team-based strategies
Register now! 🔗 bit.ly/ASCOGU25sky
#oncsky #medsky zerocancer.org | bcan.org
📢 Register for @peerview.bsky.social #GU25 symposia! bit.ly/ASCOGU25sky
#medsky #oncsky
📢 Register for @peerview.bsky.social #GU25 symposia! bit.ly/ASCOGU25sky
#medsky #oncsky
Join Drs. Geoffrey Ku, Shubham Pant, and Kanwal Raghav for our PeerView's symposium on HER2+ GI cancers at the American Society of Clinical Oncology (ASCO) #GI25.
🎬 Watch the teaser video and register now to secure your spot.
#medsky #oncsky #mededsky
#oncsky #medsky
#oncsky #medsky
🗓️ Choose Your Session:
📅 Thursday, February 13, 2025 | 7:00-8:00 PM EST
📅 Wednesday, February 19, 2025 | 12:00-1:00 PM EST
🗓️ Choose Your Session:
📅 Thursday, February 13, 2025 | 7:00-8:00 PM EST
📅 Wednesday, February 19, 2025 | 12:00-1:00 PM EST
📅 Jan 23 | 6:15 PM PST
📌 Watch & register: bit.ly/Biliary-SF25T
📅 Jan 23 | 6:15 PM PST
📌 Watch & register: bit.ly/Biliary-SF25T
Register now to join in person or online!
Register now to join in person or online!
📅 Jan 23 | 6:15 PM PST
📍 San Francisco & Virtual
✅ Personalized care strategies
✅ Integrating immunotherapy & targeted therapies
🎙 Drs. Ghassan Abou-Alfa, Lipika Goyal, James Harding, & Arndt Vogel
📌 Register now: bit.ly/ASCOGIT
📅 Jan 23 | 6:15 PM PST
📍 San Francisco & Virtual
✅ Personalized care strategies
✅ Integrating immunotherapy & targeted therapies
🎙 Drs. Ghassan Abou-Alfa, Lipika Goyal, James Harding, & Arndt Vogel
📌 Register now: bit.ly/ASCOGIT
Join us for an expert-led discussion on advancing biliary tract cancer care at #GI25.
📅 Jan 23 | 6:15 PM PST
📍 San Francisco & Virtual
💼 @cholangiocarcinoma.bsky.social
💡 Watch the teaser & register now: bit.ly/Biliary-SF25T
Join us for an expert-led discussion on advancing biliary tract cancer care at #GI25.
📅 Jan 23 | 6:15 PM PST
📍 San Francisco & Virtual
💼 @cholangiocarcinoma.bsky.social
💡 Watch the teaser & register now: bit.ly/Biliary-SF25T